Cotinga Pharmaceuticals Inc

McKesson Canada, a diversified healthcare leader, plays a critical role in advancing health outcomes through its extensive distribution network, delivering a third of all medications in Canada while providing essential care through retail pharmacy solutions. The organization combines clinical knowledge, process expertise, and technology to enhance the quality and affordability of healthcare for patients and partners alike. Additionally, McKesson Canada is committed to supporting treatment for chronic conditions and rare diseases, contributing to public policy discussions around equitable access to medications. Recently, the company has expanded patient access to innovative treatments, such as radioligand therapy, in a new infusion clinic, demonstrating its dedication to transforming patient care in the province. Generated from the website

Dermal Therapy Research, based in London, Canada, offers a range of specialized skincare products designed to address various skin conditions such as aging skin, eczema, psoriasis, and sensitive skin. Their product line includes lotions, creams, and treatments formulated to provide relief and protection for those dealing with dry, irritated skin. With a focus on quality and effectiveness, Dermal Therapy Research caters to a diverse range of skin concerns, from diabetic dry skin to exposure to outdoor elements. Customers can choose from individual products or opt for curated bundles to meet their specific skincare needs. Generated from their website

BLES Biochemicals Inc., based in London, Ontario, is a privately owned Canadian pharmaceutical company specializing in the manufacture and distribution of BLES (bovine lipid extract surfactant). With over 20 years of experience, the company is recognized as the market leader in pulmonary surfactants in Canada, particularly for the treatment of premature infants suffering from Neonatal Respiratory Distress Syndrome (NRDS). BLES is unique in that it has no generic equivalent and is well-tolerated even by the smallest patients, allowing for rapid extubation to non-invasive CPAP. The product is administered intratracheally and is known for its quick response time, significantly impacting oxygenation and lung compliance within minutes of administration. Generated from the website